| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |